Market Value5,459,959,793
Total Holdings114
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
UNH / UnitedHealth Group Incorporated
AVTE / Aerovate Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
PHGE / BiomX Inc.
ISRG / Intuitive Surgical, Inc.
NPCE / NeuroPace, Inc.
ALXO / ALX Oncology Holdings Inc.
NKTX / Nkarta, Inc.
AVBP / ArriVent BioPharma, Inc.
LYEL / Lyell Immunopharma, Inc.
NMRA / Neumora Therapeutics, Inc.
ELV / Elevance Health, Inc.
BIIB / Biogen Inc.
FATE / Fate Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc. Call
IMTX / Immatics N.V.
ORIC / ORIC Pharmaceuticals, Inc.
NSPR / InspireMD, Inc.
APLS / Apellis Pharmaceuticals, Inc.
MLYS / Mineralys Therapeutics, Inc.
NTRA / Natera, Inc.
GILD / Gilead Sciences, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
SIBN / SI-BONE, Inc.
SIBN / SI-BONE, Inc. Call
ALNY / Alnylam Pharmaceuticals, Inc.
THRD / Third Harmonic Bio, Inc.
DYN / Dyne Therapeutics, Inc.
XTNT / Xtant Medical Holdings, Inc.
PFE / Pfizer Inc. Call
GERN / Geron Corporation
VIR / Vir Biotechnology, Inc.
OMIC / Singular Genomics Systems, Inc.
ISR / Perspective Therapeutics Inc
SCPH / scPharmaceuticals Inc.
CTMX / CytomX Therapeutics, Inc.
CGEM / Cullinan Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
THC / Tenet Healthcare Corporation
VTYX / Ventyx Biosciences, Inc.
RPTX / Repare Therapeutics Inc.
MRK / Merck & Co., Inc.
SRRK / Scholar Rock Holding Corporation
RAPT / RAPT Therapeutics, Inc.
ELVN / Enliven Therapeutics, Inc.
EXAS / Exact Sciences Corporation
RNA / Avidity Biosciences, Inc.
SLRN / Acelyrin, Inc.
NBIX / Neurocrine Biosciences, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
AFIB / Acutus Medical, Inc.
CALC / CalciMedica, Inc.
TELA / TELA Bio, Inc.
BSX / Boston Scientific Corporation
FOLD / Amicus Therapeutics, Inc.
LLY / Eli Lilly and Company
RYTM / Rhythm Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
SYK / Stryker Corporation
CMPX / Compass Therapeutics, Inc.
IRON / Disc Medicine, Inc.
MIST / Milestone Pharmaceuticals Inc.
EVH / Evolent Health, Inc.
/ Fusion Networks Holdings, Inc.
AMAM / Ambrx Biopharma Inc.
UTHR / United Therapeutics Corporation
HUM / Humana Inc.
INVA / Innoviva, Inc.
RCUS / Arcus Biosciences, Inc.
CLDX / Celldex Therapeutics, Inc.
RCM / R1 RCM Inc.
QURE / uniQure N.V.
RYZB / RayzeBio, Inc.
ILMN / Illumina, Inc.
BOLT / Bolt Biotherapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
AMGN / Amgen Inc.
PRAX / Praxis Precision Medicines, Inc.
IKENA ONCOLOGY INC / NONVOTING (000000000)
SVA / Sinovac Biotech, Ltd.
TXG / 10x Genomics, Inc.
DVAX / Dynavax Technologies Corporation
ARWR / Arrowhead Pharmaceuticals, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
VIGL / Vigil Neuroscience, Inc.
HRTX / Heron Therapeutics, Inc.
TSBX / Turnstone Biologics Corp.
SWTX / SpringWorks Therapeutics, Inc.
PASG / Passage Bio, Inc.
XFOR / X4 Pharmaceuticals, Inc.
ACET / Adicet Bio, Inc.
CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock)
IONS / Ionis Pharmaceuticals, Inc.
XERS / Xeris Biopharma Holdings, Inc.
MORF / Morphic Holding, Inc.
ICLR / ICON Public Limited Company
PGNY / Progyny, Inc.
DXCM / DexCom, Inc.
KNTE / Kinnate Biopharma Inc.
IVVD / Invivyd, Inc.
SRPT / Sarepta Therapeutics, Inc.
LSB / LakeShore Biopharma Co., Ltd
BMRN / BioMarin Pharmaceutical Inc.
QTTB / Q32 Bio Inc.
TYRA / Tyra Biosciences, Inc.
CRVS / Corvus Pharmaceuticals, Inc.
KROS / Keros Therapeutics, Inc.
TMO / Thermo Fisher Scientific Inc.
PMVP / PMV Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
NXTC / NextCure, Inc.
ABCL / AbCellera Biologics Inc.
VERA / Vera Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ELEV / Elevation Oncology, Inc.
CYTK / Cytokinetics, Incorporated
SPRY / ARS Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
PRLD / Prelude Therapeutics Incorporated
ALPN / Alpine Immune Sciences, Inc.
JANX / Janux Therapeutics, Inc.
ESPR / Esperion Therapeutics, Inc.
VSTM / Verastem, Inc.
IKNA / Ikena Oncology, Inc.
APLM / Apollomics, Inc.
TERN / Terns Pharmaceuticals, Inc.